Skip to main content
Toggle navigation
Login
Home
iwCLL X / Twitter
Favorite
Tweet
Edyta Cichocka, MD, PhD
Department of Haematology, Rydygiera Hospital in Torun, Poland
Poster(s):
1406 - Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult Leukemia Group